Happy to share this editorial on challenges and opportunities for TB research during #COVID19 in @IJTLD written with twitter-less collaborators in both Georgias 🇬🇪🇺🇸 theunion.org/news/tb-resear… #EndTB @EmoryInfectDis

1/ I asked how I could improve, but they just said ‘Everything was great.’ But I know that there are things I could do better. As a learner or supervisor, have you found it hard to get honest, actionable feedback about your teaching? This week's #tweetorial: Soliciting Feedback

Excellent meta-analysis on the sensitivity and specificity of stool Xpert for diagnosing TB disease in children led by Fogarty at NIH trainee Dr. Meseret Gebre and our colleagues Armauer Hansen featured as an Editor’s Choice article in the August issue of OFID. academic.oup.com/ofid/article/8…

Thanks to Matt Magee for presenting “TB, Pulmonary Impairment and stress hyperglycemia” at our Works in Progress meeting today. He shared design and plans for the NIAID News funded MIDST TB study and preliminary findings of Fogarty at NIH funded PITT study.

New paper published in PLOS Pathogens by Emory/Georgia TB Research Advancement Center-TRAC investigators. Using immunometabolic profiling of plasma from multiple pulmonary TB cohorts they show a close association between remodeling of TCA cycle intermediates and pathologic inflammation. dx.plos.org/10.1371/journa…

Proud of this collaboration in #OFID showing use of Xpert mtb/rif assay is associated with decreased time to appropriate therapy and culture conversion in smear-negative MDR-TB in Georgia 🇬🇪 #EndTB Emory/Georgia TB Research Advancement Center-TRAC academic.oup.com/ofid/article/8…

In #PLHIV from Myanmar, Emory Public Health and Georgia State University • School of Public Health investigators found increased #TB incidence due to synergy between low BMI and hyperglycemia. Participants with HIV who had low BMI and hyperglycemia had a TB incidence of 21 per 100 person years. journals.lww.com/aidsonline/Abs…

A new report in CID describes the rapid detection of the #Omicron variant in a returning traveler to Georgia using a combination of targeted spike SNP PCR and viral genome sequencing. 📄:bit.ly/3Kkddip #IDSAJournals #ClinInfectDis @AnnePiantadosi

Emory investigators, led by Matthew Magee, examined >500,000 patients with TB infection. They found an increased risk of diabetes incidence, suggesting subclinical LTBI may have metabolic sequela. Findings were just published in Diabetes Care (ADA Professional Publications). diabetesjournals.org/care/article-a…

Proud to be 1/4 TRAC sites announced today: "NIH funds new tuberculosis research advancement centers | National Institutes of Health (NIH)" Emory/Georgia TB Research Advancement Center-TRAC Neel Gandhi @RengarajanLab Emory Public Health @EmoryInfectDis nih.gov/news-events/ne…

From Eli Wilber MD, Joseph Sharp, @justalisongrace, GradyHealth: Low rates of antibiotic use among ambulatory patients with coronavirus disease 2019 (#COVID19) bit.ly/3v9eZfO

Pleased to finally share this team effort describing seroprevalence among healthcare workers early in the COVID pandemic with collaborators from Emory SOM at Grady Hospital @EmoryInfectDis GradyHealth doi.org/10.1016/j.amjm…

Great work by @HVerkerke Greg Damhorst @EmoryInfectDis

🆕⚡#AAC Cytopenias occurred frequently with long-term use of linezolid 600 mg/day and were associated with PK parameters but did not result in the need for treatment interruption in the management of a cohort of patients with MDR-TB #IDTwitter journals.asm.org/doi/10.1128/aa…

We found that while cytopenias are common during MDR-TB treatment including linezolid 600mg/day and are associated with PK parameters, patients did not require treatment interruption. An important med to #EndTB Emory/Georgia TB Research Advancement Center-TRAC @EmoryInfectDis journals.asm.org/doi/10.1128/aa…

Thanks to a great team led by Sarita Shah

An important mimic of cutaneous cryptococcal disease - a collaboration between @EmoryInfectDis Emory University Department of Pathology Emory Dermatology including Ariel Jordan, MD Stewart G. Neill Jeff Collins

Kinetics of the Antibody Response to Symptomatic SARS-CoV-2 Infection in Vaccinated and Unvaccinated Individuals in the Blinded Phase of the mRNA-1273 COVID-19 Vaccine Efficacy Trial ✅ Just Accepted 🔓 Open Access 🔗 bit.ly/3HSW92R #OFIDEditorsChoice